A scientific reference in its sector of activity.
Vésale Pharma, a pioneer in its field, specializes in the clinical and galenical research and development of based probiotics treatments.
From the beginning, Vésale Pharma has set up a vast R&D plan in its various therapeutic areas.
These research programs pursue a major objective: to develop new safe and effective health products and innovative pharmaceutical products for major health and well-being needs that have not yet been satisfactorily addressed.
Vésale Pharma works in partnership with university research teams from the University of Liège and Ghent (Belgium) and from the Texas A&M University (USA) or with the Institut Pasteur in Lille, as well as Belgian and international laboratories and medical practitioners.
All strains of Vésale Pharma are documented; they have been and still are the subject of R&D.
The company holds several worldwide patents (notably the revolutionary Intelicaps® patent), Vésale Pharma currently structures its Research & Development activity around several major axes: Immunity, Intelicaps technology and anti-infective treatments.
Посмотреть все товары бренда VESALEPHARMA
Vésale Pharma works in partnership with university research teams from the University of Liège and Ghent (Belgium) and from the Texas A&M University (USA) or with the Institut Pasteur in Lille, as well as Belgian and international laboratories and medical practitioners.
All strains of Vésale Pharma are documented; they have been and still are the subject of R&D.
The company holds several worldwide patents (notably the revolutionary Intelicaps® patent), Vésale Pharma currently structures its Research & Development activity around several major axes: Immunity, Intelicaps technology and anti-infective treatments.
Посмотреть все товары бренда VESALEPHARMA